Deficient tumor‐specific immunity in old mice: in vivo mediation by suppressor cells, and correction of the defect by interleukin 2 supplementation in vitro but not in vivo
- 1 January 1987
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 17 (3) , 307-312
- https://doi.org/10.1002/eji.1830170302
Abstract
The capacity of old (18–24 months) C57BL/6 mice to develop an immune reaction against MC-B6-1 fibrosarcoma cells was studied using in vivo adoptive transfer experiments (Winn assay) and in vitro T cell-mediated cytotoxicity test. Anti-tumor immunity was found to decline with age, as indicated by a decreased anti-tumor growth T cell activity. A suppressive activity was also found present in the splenic T cell population of old mice which can inhibit the in vivo generation of immune T cells in young mice. These suppressors, or their precursors, were resistant to cyclophosphamide treatment and were effective only when administered 3 days before the immunization of young mice. These mice developed immune T cells perfectly when the suppressors were administered 3 days after immunization, indicating that suppressors may act at an early phase of T cell activation. The protective activity of T cells in vivo correlated well with the in vitro T cell cytotoxicity for MC-B6-1 tumor cells, as both were depressed in old mice. Exogenous interleukin 2 (IL 2) addition during the 4-day culture period partially restored the low cytotoxic activity of old immunized lymphocytes, suggesting that specific clones were present but that a lack of IL 2 limited their expansion. However, in vivo supplementation with IL 2 administered after immunization did not increase the protection mediated by old immunized T cells but, rather, increased the suppression. This work demonstrates the presence of a T cell suppressive activity in the spleen of old mice but also indicates that precursors of cytotoxic cells are generated by the immunization. It seems that in vitro IL 2 addition increases cytotoxic cells while in vivo IL 2 administration amplifies the development of suppressor cells generated during immunization of aged mice.This publication has 19 references indexed in Scilit:
- Deficiency in suppressor T cell activity in aged animals. Reconstitution of this activity by interleukin 2.The Journal of Experimental Medicine, 1983
- Role of T cells and adherent cells in age-related decline in murine interleukin 2 production.The Journal of Immunology, 1982
- Cytotoxic activity of lymphoid cells from mice immunized with semiallogeneic hybrid cells: Requirement of in vitro lymphoid cells culture for expression of cytotoxicity against a syngeneic chemically induced tumorCellular Immunology, 1982
- Mechanisms Involved in Age‐dependent Decline of Immune Responsiveness and Apparent Resistance against Tolerance Induction in C57BL/6 MiceScandinavian Journal of Immunology, 1982
- Cell-mediated immunity in aged mice: an underlying lesion in IL 2 synthesis.The Journal of Immunology, 1982
- Changes in suppressor, helper, and B-cell functions in aging miceCellular Immunology, 1982
- Lymphokines and aging: interleukin-2 production and activity in aged animals.The Journal of Immunology, 1981
- Adoptive transfer of immunity induced by semi-allogeneic hybrid cells, against a murine fibrosarcomaInternational Journal of Cancer, 1981
- T Cell Growth Factor: Parameters of Production and a Quantitative Microassay for ActivityThe Journal of Immunology, 1978
- Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice.The Journal of Experimental Medicine, 1976